Insiders info
|
4
|
Resverlogix Corp.
|
Aug 08, 2015 04:22PM
|
Re: Sept 30 2022 - Resverlogix streaming video
|
4
|
Resverlogix Corp.
|
Sep 30, 2022 08:37AM
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
4
|
Resverlogix Corp.
|
Jun 13, 2016 07:00PM
|
Re: Is volume going to turn the corner?
|
4
|
Resverlogix Corp.
|
Nov 08, 2019 08:00AM
|
Re: AGM - High Level Summary
|
4
|
Zenith Epigenetics
|
Jan 13, 2016 08:58AM
|
Re: Hong Kong stock exchange IPO
|
4
|
Resverlogix Corp.
|
Apr 26, 2018 02:16PM
|
Re: Drug Discovery Targeting BRD4
|
4
|
Resverlogix Corp.
|
Oct 04, 2017 05:09PM
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
4
|
Resverlogix Corp.
|
Mar 26, 2022 07:24AM
|
Re: TLD Confidence
|
4
|
Resverlogix Corp.
|
Aug 27, 2019 03:00PM
|
Re: American Society of Nephrology Kidney Week
|
4
|
Resverlogix Corp.
|
Nov 04, 2017 12:36PM
|
Re: No word on...
|
4
|
Resverlogix Corp.
|
Jul 15, 2021 10:46AM
|
Long Covid remains a big challenge
|
4
|
Resverlogix Corp.
|
Jul 24, 2023 07:20PM
|
Re: RVX announces...THIS IS FROM RVX
|
4
|
Resverlogix Corp.
|
Oct 13, 2017 11:29AM
|
The Complement System - Beacon Nov 17 2017
|
4
|
Resverlogix Corp.
|
May 16, 2018 04:26PM
|
Re: Yet another potential indication: Reduction of drug-seeking behavior
|
4
|
Resverlogix Corp.
|
Oct 26, 2021 06:44PM
|
Re: ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
4
|
Zenith Epigenetics
|
Mar 10, 2016 03:49PM
|
Re: New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
4
|
Resverlogix Corp.
|
May 15, 2016 05:04PM
|
Re: Zenith AGM
|
4
|
Zenith Epigenetics
|
Nov 22, 2023 06:20PM
|
Re: Just back from IR,...
|
4
|
Resverlogix Corp.
|
Oct 29, 2019 02:49PM
|
Re: RVX announces first right of refusal for license deal in the US
|
4
|
Resverlogix Corp.
|
Oct 24, 2017 01:10PM
|